Search Results (1 to 10 of 1852 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 501 Journal of Medical Internet Research
- 339 JMIR Research Protocols
- 228 JMIR Formative Research
- 158 JMIR mHealth and uHealth
- 88 JMIR Public Health and Surveillance
- 72 JMIR Mental Health
- 69 Online Journal of Public Health Informatics
- 55 JMIR Medical Informatics
- 49 JMIR Human Factors
- 30 JMIR Cancer
- 28 JMIR Aging
- 28 JMIR Pediatrics and Parenting
- 26 JMIR Serious Games
- 24 JMIR Dermatology
- 23 JMIR Medical Education
- 21 Iproceedings
- 20 Interactive Journal of Medical Research
- 19 JMIR Diabetes
- 14 JMIRx Med
- 12 JMIR Rehabilitation and Assistive Technologies
- 10 JMIR Infodemiology
- 9 JMIR Perioperative Medicine
- 7 JMIR AI
- 7 Journal of Participatory Medicine
- 4 JMIR Cardio
- 3 JMIR Biomedical Engineering
- 2 JMIR Neurotechnology
- 2 JMIR Nursing
- 2 Medicine 2.0
- 1 Asian/Pacific Island Nursing Journal
- 1 JMIR Data
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR XR and Spatial Computing (JMXR)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Of over 3000 potential donors referred between 2010 and 2015, approximately 10% had increased risk behaviors for blood-borne viruses (hepatitis B, hepatitis C, and HIV), but the majority were deemed not medically suitable for organ donation without specific testing to confirm or refute virus exposure [16]. Those potential donors who were tested showed a
Schema of the NSW deceased organ donor referral process. NSW: New South Wales.
JMIR Res Protoc 2025;14:e67588
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Sodium oxybate, the pharmacological agent used in this study, acts as a GABA-B receptor agonist and a precursor of GABA [24]. It was administered in doses ranging between 0.01 and 0.1 g/kg, 3 times daily either orally or intravenously (equivalent to 2.4-24 g/d for an 80 kg patient). Among patients with schizophrenia and catatonia, approximately 30 participants, the study showed a reduction of catatonic symptoms ranging from 60% to 70%.
JMIR Res Protoc 2025;14:e68356
Download Citation: END BibTex RIS